Cheng-Hsun Chuang^1,2,3,#, Ping-Kun Tsai^3,4,5,6,#, Shih-Wen Kao^7,8, Yu-Hsun Wang^8,9,*, Chao-Bin Yeh^1,2,3,*

Oncology Research, Vol.34, No.1, 2026, DOI:10.32604/or.2025.072875 - 30 December 2025

Abstract Background: To determine whether initiating a glucagon-like peptide-1 receptor agonist (GLP-1 RA) within 3 months of type 2 diabetes (T2DM) diagnosis alters the subsequent risk of overall and site-specific cancer and whether this association differs by baseline body-mass index (BMI). Methods: This retrospective cohort study used electronic health records from the TriNetX U.S. research network. Adults aged 20 years or older diagnosed with T2DM between 2016 and 2024 were included if they received any hypoglycemic agents within 3 months before and after diagnosis. Following 1:1 propensity score matching, both the GLP-1 RA user and non-user… More > Graphic Abstract

Helen Fenske¹, Ingrid R. Niesman^2,*

BIOCELL, Vol.49, No.12, pp. 2433-2455, 2025, DOI:10.32604/biocell.2025.071078 - 24 December 2025

Abstract Objective: Tyrosinase is the rate-limiting enzyme in the generation of melanin. The feline tyrosinase mutation, G302R, confers temperature-sensitive loss of function, resulting in the familiar Siamese cat phenotype. Crystal or cryoEM structures are elusive for any mammalian tyrosinase to date. Protein misfolding is suggested as a basis for phenotypes resulting from mutant tyrosinases, but this hypothesis needs structural confirmation. Our objective for this study is to confirm misfolding of mutant tyrosinase as a basis for temperature-sensitive phenotypes compared to catalytic dysfunction that may be responsible for other tyrosinase mutant breed phenotypes. Methods: We have employed… More >

Seo Yeon Shin¹, Nu Ri Song¹, Sa Rang Choi¹, Ki Min Kim¹, Jae Hee Byun¹, Su Jung Kim², Dai Hyun Jung², Seong Sim Kim², Seong Ju Park², So Jeong Chu², Kyung Mok Park^1,*

BIOCELL, Vol.49, No.8, pp. 1435-1448, 2025, DOI:10.32604/biocell.2025.065199 - 29 August 2025

Abstract Background: The efficient transdermal delivery of biologically active molecules remains a major challenge because of the structural barrier of the stratum corneum, which limits the penetration of large or hydrophilic molecules. Low-molecular-weight protamine (LMWP) has a structure similar to that of the HIV TAT protein-derived peptide and is a representative cell-penetrating peptide (CPP) used to increase cell permeability. However, protamine has been reported to have many toxicities and side effects. Objectives: We developed human-derived low-molecular-weight protamine (hLMWP), which is based on fish-derived LMWP but designed using human protein sequences to improve safety and functionality. As… More > Graphic Abstract

Wenfei Luo^1,#, Dingming Song^2,#, Yibo He³, Judong Song^4,*, Yunzhen Ding^5,*

Oncology Research, Vol.33, No.8, pp. 1875-1893, 2025, DOI:10.32604/or.2025.063843 - 18 July 2025

Abstract Malignant melanoma, characterized by its high metastatic potential and resistance to conventional therapies, presents a major challenge in oncology. This review explores the current status and advancements in tumor vaccines for melanoma, focusing on peptide, DNA/RNA, dendritic cell, tumor cell, and neoantigen-based vaccines. Despite promising results, significant challenges remain, including the immunosuppressive tumor microenvironment, patient heterogeneity, and the need for more effective antigen presentation. Recent strategies, such as combining vaccines with immune checkpoint inhibitors (ICIs), aim to counteract immune evasion and enhance T cell responses. Emerging approaches, including personalized neoantigen vaccines and the use of More > Graphic Abstract

HAFIZ MUHAMMAD REHMAN^1,2,*, SIDRA AHMAD², AZEEM SARWAR¹, HAMID BASHIR^2,*

Oncology Research, Vol.33, No.7, pp. 1547-1570, 2025, DOI:10.32604/or.2025.062197 - 26 June 2025

Abstract Targeted cancer therapy has emerged as a promising alternative to conventional chemotherapy, which is often plagued by poor selectivity, off-target effects, and drug resistance. Among the various targeting agents in development, peptides stand out for their unique advantages, including minimal immunogenicity, high tissue penetration, and ease of modification. Their small size, specificity, and flexibility allow them to target cancer cells while minimizing damage to healthy tissue selectively. Peptide-based therapies have shown great potential in enhancing the efficacy of drug delivery, improving tumor imaging, and reducing adverse effects. With cancer responsible for millions of deaths worldwide,… More >

Chaichawin Chavapradit¹, Wonnop Visessanguan², Suwan Panjanapongchai¹, Anil Kumar Anal^1,*

Journal of Renewable Materials, Vol.13, No.3, pp. 553-582, 2025, DOI:10.32604/jrm.2025.058857 - 20 March 2025

Abstract The growing population and industrialization have led to significant production in agro-industrial sectors, resulting in large amounts of agro-industrial residues often left untreated, posing potential environmental issues. Therefore, finding effective ways to utilize these bio-based residues is crucial. One promising approach is to use these low- or no-value agro-industrial wastes as raw materials for producing renewable biomaterials, including proteins and peptides. Research has extensively explored peptide extraction using plant and animal-based agro-industrial residue. Due to lower processing costs and beneficial bioactive properties, peptides derived from waste could replace synthetic peptides and those extracted from food More >

Junhui Yan¹, Yawen Wang¹, Qiong Li¹, Yu Zhou², Xu Wang^2,*, Li Luo^1,*

Phyton-International Journal of Experimental Botany, Vol.93, No.6, pp. 1237-1248, 2024, DOI:10.32604/phyton.2024.051517 - 27 June 2024

Abstract Rhizobia induces nitrogen-fixing nodules in legumes used in agricultural production, providing a direct source of combined nitrogen to leguminous crops. Small peptides, such as CLAVATA3/EMBRYO SURROUNDING REGION peptides (CLE), are known to regulate the formation and development of nitrogen-fixing nodules in legumes. Root meristem growth factor (RGF) peptides from Medicago truncatula not only regulate root development but also modulate nodulation symbiosis with Sinorhizobium meliloti. However, the impact of RGF peptides from one leguminous species on the others remains unclear. In this study, we investigate the effects of the RGF family peptide MtRGF6p from M. truncatula on nodulation symbiosis… More >

CARLOS ALBERTO-SILVA^*, BRENDA RUFINO DA SILVA

BIOCELL, Vol.48, No.6, pp. 897-904, 2024, DOI:10.32604/biocell.2024.050443 - 10 June 2024

Abstract Venom snake-derived peptides have multiple biochemical, pharmacological, and toxicological profiles, allowing for the discovery of new medicinal products and therapeutic applications. This review specifically examines the fundamental elements of neuroprotection offered by different oligopeptides derived from snake venom. It also includes a brief evaluation of short peptides that are being considered as potential therapeutic agents. Proline-rich peptides and tryptophyllin family peptides isolated from the crude venom of Viperidae family snakes, specifically Bothrops atrox, Bothrops jararaca, and Bothrops moojeni, have been shown to have pro-survival properties, the ability to reduce oxidative stress, and the ability to promote cell viability More >

HYUNHO KIM¹, UIJU CHO², SOOK HEE HONG³, HYUNG SOON PARK¹, IN-HO KIM³, HO JUNG AN¹, BYOUNG YONG SHIM¹, JIN HYOUNG KANG^3,*

Oncology Research, Vol.32, No.6, pp. 1021-1030, 2024, DOI:10.32604/or.2024.048919 - 23 May 2024

Abstract Background: Apolipoprotein B mRNA editing catalytic polypeptide (APOBEC), an endogenous mutator, induces DNA damage and activates the ataxia telangiectasia and Rad3-related (ATR)-checkpoint kinase 1 (Chk1) pathway. Although cisplatin-based therapy is the mainstay for muscle-invasive bladder cancer (MIBC), it has a poor survival rate. Therefore, this study aimed to evaluate the efficacy of an ATR inhibitor combined with cisplatin in the treatment of APOBEC catalytic subunit 3B (APOBEC3B) expressing MIBC. Methods: Immunohistochemical staining was performed to analyze an association between APOBEC3B and ATR in patients with MIBC. The APOBEC3B expression in MIBC cell lines was assessed… More >

MOHAMAD ZULKEFLEE SABRI¹, JOANNA BOJARSKA², FAI-CHU WONG^3,4, TSUN-THAI CHAI^3,4,*

BIOCELL, Vol.47, No.8, pp. 1727-1742, 2023, DOI:10.32604/biocell.2023.029272 - 28 August 2023

Abstract Molecular dynamics (MD) simulation is a computational technique that analyzes the movement of a system of particles over a given period. MD can provide detailed information about the fluctuations and conformational changes of biomolecules at the atomic level over time. In recent years, MD has been widely applied to the discovery of peptides and peptide-like molecules that may serve as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) inhibitors. This review summarizes recent advances in such explorations, focusing on four protein targets: angiotensin-converting enzyme 2 (ACE2), spike protein (S protein), main protease (M^pro), and papain-like protease (PL^pro).… More > Graphic Abstract